Leveraging Platform Technology for a Differentiated Gene Therapy Approach

  • Developing a high purity product profile that reduces total viral load while maximizing efficacy with a novel construct
  • Pivotal trial designed with external controls to show differentiation
  • Implementing a proactive, short-course immune modulation regimen designed to improve safety outcomes